Organon & CO Form 4 insider transactions

Director Carrie Smith Cox reports acquiring phantom stock units in Organon & Co. through the company's Non-Employee Director Savings Plan.

Director Deborah R. Leone reports acquiring phantom stock units in Organon & Co. through a non-employee director savings plan.

Director Robert Essner reports acquisition of phantom stock units in Organon & Co. through a non-employee director savings plan.

Director Martha E. McGarry reports acquisition of phantom stock units in Organon & Co. through a dividend reinvestment and the Non-Employee Director Savings Plan.

Director Grace Puma Whiteford reports acquiring phantom stock units in Organon & Co. through a non-employee director savings plan.

Director Phillip Ozuah reports acquiring phantom stock units in Organon & Co. through a non-employee director savings plan.

Director Rochelle B. Lazarus reports acquiring phantom stock units in Organon & Co. through the company's Non-Employee Director Savings Plan.

Joseph T. Morrissey, Jr., Head of Manufacturing at Organon & Co., reports the vesting of restricted stock units and subsequent stock transactions on May 4, 2024.

Vittorio Nisita, Head of Global Business Services at Organon & Co., reports the vesting of restricted stock units and subsequent stock transactions.

Chief Commercial Officer Susanne Fiedler reports the vesting of restricted stock units and subsequent disposition of shares to cover tax obligations.

CEO Kevin Ali reports the vesting and disposal of Organon & Co. stock and restricted stock units on May 4, 2024.

Kirke Weaver, General Counsel & Corporate Secretary of Organon & Co., reports the vesting and disposal of restricted stock units and common stock transactions on May 4, 2024.

Chief Human Resources Officer Aaron Falcione reports the vesting of restricted stock units and subsequent stock sales.

Kathryn DiMarco, Corporate Controller of Organon & Co., reports the vesting and disposal of restricted stock units and common stock transactions.

Chief Financial Officer of Organon & Co., Matthew Walsh, reports the vesting and disposal of restricted stock units and common stock transactions on May 4, 2024.

Chief Information Officer Rachel A. Stahler reports the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.

Juan Camilo Arjona Ferreira, Head of R&D & CMO at Organon & Co., received stock options and restricted stock units (RSUs) on March 29, 2024, according to a Form 4 filing.

Joseph T. Morrissey, Jr., Head of Manufacturing at Organon & Co., reports the vesting and conversion of restricted stock units into common stock, along with associated tax withholding dispositions.

Chief Commercial Officer Susanne Fiedler reports the vesting and subsequent disposal of Organon & Co. stock units on March 31, 2024.

Chief Financial Officer Matthew Walsh reports transactions involving Organon & Co. common stock and restricted stock units.

Rachel A. Stahler, Chief Information Officer of Organon & Co., reports the vesting and disposal of restricted stock units and subsequent acquisition of common stock on March 31, 2024.

Vittorio Nisita, Head of Global Business Services at Organon & Co., reports the vesting and subsequent sale of restricted stock units on March 31, 2024.

CEO Kevin Ali reports the vesting and conversion of restricted stock units into Organon & Co. common stock, along with the disposition of shares to cover tax obligations.

Aaron Falcione, Chief Human Resources Officer of Organon & Co., reports the vesting and disposition of restricted stock units.

Kirke Weaver, General Counsel & Corporate Secretary of Organon & Co., reports the vesting and disposal of restricted stock units (RSUs) on March 31, 2024.

Kathryn DiMarco, Corporate Controller of Organon & Co., reports transactions involving common stock and restricted stock units on March 31, 2024.

Organon & Co. CEO Kevin Ali was granted stock options and restricted stock units on March 29, 2024, according to a Form 4 filing with the SEC.

Aaron Falcione, Chief Human Resources Officer of Organon & Co., reports the acquisition of stock options and restricted stock units.

Chief Commercial Officer Susanne Fiedler reports the acquisition of restricted stock units and stock options in Organon & Co.

Joseph T. Morrissey, Jr., Head of Manufacturing at Organon & Co., reports the acquisition of stock options and restricted stock units.